The goal of this study is to test the maximum tolerated dose of ACU-D1 in HIV-positive people with HPV-associated vulvar and perianal lesions. The main questio…

Human Papilloma VirusHuman Immunodeficiency VirusAnal Intraepithelial Neoplasia+1 more

~Estimated

~$10 – $6,250

Emory UniversityNCT06233331

Phase 1

A Phase I Study of Intra-anally Administered Lopinavir/Ritonavir in People Living With HIV (PLWH) With High-Grade Anal Intraepithelial Neoplasia (AIN 2/3)

This study is being done to assess the safety of lopinavir/ritonavir in patients with PLWH with AIN. 30 participants will be recruited and can expect to be on …

High-Grade Anal Intraepithelial Neoplasia

~Estimated

~$10 – $6,250

University of Wisconsin, MadisonNCT05334004

Phase 4

Prospective Observational Immunogenicity Trial of Gardasil-9 HPV Vaccine in People Living With Adequately Managed HIV

The primary objective of this study is to determine the magnitude and breadth of the serum antibody response to the nonavalent HPV vaccine (Gardasil-9) in adul…

Papillomavirus VaccinesHuman Immunodeficiency VirusPapillomavirus Infection+4 more

~Estimated

~$10 – $6,250

Louisiana State University Health Sciences Center in New OrleansNCT05266898